Bukofzer Stan
Insider CIK 1663041 · DEPO SVP, Chief Medical Officer · OCRX Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ASRT Assertio Therapeutics, Inc | M Exercise deriv | 2020-04-02 | 2020-04-03 | 25,370 | — | $0 | 40,584 | SEC↗ |
| ASRT Assertio Therapeutics, Inc | M Exercise deriv | 2020-04-02 | 2020-04-03 | 25,370 | — | $0 | 40,584 | SEC↗ |
| ASRT Assertio Therapeutics, Inc | F Tax w/h | 2020-04-02 | 2020-04-03 | 7,433 | — | $0 | 62,916 | SEC↗ |
| ASRT Assertio Therapeutics, Inc | M Exercise | 2020-04-02 | 2020-04-03 | 25,370 | — | $0 | 70,349 | SEC↗ |
| ASRT Assertio Therapeutics, Inc | M Exercise | 2020-04-02 | 2020-04-03 | 25,370 | — | $0 | 70,349 | SEC↗ |
| ASRT Assertio Therapeutics, Inc | F Tax w/h | 2020-04-02 | 2020-04-03 | 7,433 | $0.65 | $4.8K | 62,916 | SEC↗ |
| ASRT Assertio Therapeutics, Inc | M Exercise deriv | 2020-02-12 | 2020-02-12 | 27,588 | — | $0 | 55,175 | SEC↗ |
| ASRT Assertio Therapeutics, Inc | M Exercise | 2020-02-12 | 2020-02-12 | 27,588 | — | $0 | 54,524 | SEC↗ |
| ASRT Assertio Therapeutics, Inc | F Tax w/h | 2020-02-12 | 2020-02-12 | 9,545 | $1.35 | $12.9K | 44,979 | SEC↗ |
| ASRT Assertio Therapeutics, Inc | A Award deriv | 2020-02-04 | 2020-02-06 | 326,577 | — | $0 | 326,577 | SEC↗ |
| ASRT Assertio Therapeutics, Inc | P Buy | 2019-08-13 | 2019-08-14 | 4,000 | $1.56 | $6.2K | 26,936 | SEC↗ |
| ASRT Assertio Therapeutics, Inc | M Exercise deriv | 2019-04-02 | 2019-04-03 | 25,370 | — | $0 | 65,954 | SEC↗ |
| ASRT Assertio Therapeutics, Inc | M Exercise | 2019-04-02 | 2019-04-03 | 25,370 | — | $0 | 30,370 | SEC↗ |
| ASRT Assertio Therapeutics, Inc | F Tax w/h | 2019-04-02 | 2019-04-03 | 7,434 | $5.16 | $38.4K | 22,936 | SEC↗ |
| ASRT Assertio Therapeutics, Inc | P Buy | 2019-03-14 | 2019-03-18 | 5,000 | $4.13 | $20.6K | 5,000 | SEC↗ |
| ASRT Assertio Therapeutics, Inc | A Award deriv | 2019-02-12 | 2019-02-14 | 82,763 | — | $0 | 82,763 | SEC↗ |
| ASRT Assertio Therapeutics, Inc | A Award deriv | 2019-02-12 | 2019-02-14 | 18,570 | — | $0 | 18,570 | SEC↗ |
| DEPO DEPOMED INC | A Award deriv | 2018-04-02 | 2018-04-04 | 91,324 | — | $0 | 91,324 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer deriv | 2017-12-11 | 2017-12-11 | 300,000 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer deriv | 2017-12-11 | 2017-12-11 | 208,350 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer | 2017-12-11 | 2017-12-11 | 200,000 | $1.52 | $304.0K | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer | 2017-12-11 | 2017-12-11 | 2,500 | $1.52 | $3.8K | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award | 2017-03-29 | 2017-03-30 | 200,000 | — | $0 | 202,500 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2016-12-15 | 2016-12-16 | 208,350 | — | $0 | 208,350 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | P Buy | 2016-10-13 | 2016-10-17 | 2,500 | $2.64 | $6.6K | 2,500 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2016-01-05 | 2016-01-07 | 300,000 | — | $0 | 300,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2016-01-05 | 2016-01-07 | 100,000 | — | $0 | 100,000 | SEC↗ |